SCHEMBL6709148

SCHEMBL6709148

N#Cc1ccc(NC(=O)c2cc3cccc(NC(=O)COc4ccccc4)c3[nH]2)c(-c2nnn[nH]2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.38
LMNA P02545 5/20 0.37
KMT2A Q03164 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
KDM4E B2RXH2 3/20 0.37
MEN1 O00255 3/20 0.37
POLB P06746 3/20 0.37
MAPT P10636 3/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 2/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
PLA2G1B P04054 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
TP53 P04637 3/20 0.36
ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708836 0.95 MEN1 (0.42) ALDH1A1LMNAKMT2AKDM4EMEN1
SCHEMBL6712259 0.91 GAA (0.38) LMNAPOLBMAPTGAATP53
SCHEMBL6713713 0.90 ADORA3 (0.37) LMNAPOLBMAPTTP53ADORA3
SCHEMBL6708802 0.89 POLB (0.35) ALDH1A1LMNASMN1; SMN2POLBMAPT
SCHEMBL6712023 0.89 RAB9A (0.46) ALDH1A1LMNAKMT2ASMN1; SMN2KDM4E
SCHEMBL6710114 0.89 KMT2A (0.42) ALDH1A1LMNAKMT2ASMN1; SMN2KDM4E
SCHEMBL6711927 0.89 PARP14 (0.44) LMNAPOLBMAPTTP53
SCHEMBL6710250 0.89 KMT2A (0.42) KMT2AMEN1NPC1RAB9ATP53
SCHEMBL6709018 0.88 PKM (0.35) LMNAPOLBMAPTTP53RXFP1
SCHEMBL6714403 0.88 PARP14 (0.37) ALDH1A1KDM4EPOLBHPGDADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 ALDH1A1 123/4885LMNA 4062/4885KMT2A 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.